Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2023-10-23 Transaction in Own Shar…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its subject matter as "Transaction in Own Shares" and details the purchase of ordinary shares by the company as part of a "share buyback programme." It provides specific details on the number of shares purchased, the price paid, and the resulting treasury share count and total voting rights. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS (the news service of the London Stock Exchange) confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2023-10-23 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject is a 'Transaction in Own Shares' and details the purchase of 100,000 ordinary shares as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company buying back or selling its own shares. The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the specific content points overwhelmingly to POS.
2023-10-20 English
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document explicitly announces a 'Transaction in Own Shares' and details the number of ordinary shares purchased by the company on a specific date (18 October 2023) as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2023-10-19 English
Proposal to acquire Freeline Therapeutics
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated October 18, 2023. It announces a specific corporate action: Syncona Limited's proposal to acquire Freeline Therapeutics. This is a material, non-routine corporate event announcement. While it mentions filings (SEC 13D amendment, Freeline 6K), the primary purpose of this text is the announcement itself, which is characteristic of a general regulatory news service release. Since it is not a standard financial report (10-K, IR, ER) or a specific corporate action like a dividend (DIV) or share repurchase (POS), and it is clearly distributed via RNS, the most appropriate classification is the general regulatory announcement category, RNS.
2023-10-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Transaction in Own Shares' and details the purchase of 245,000 ordinary shares as part of a 'share buyback programme'. This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance). The RNS Number and the mention of the London Stock Exchange confirm it is a regulatory filing, but the specific content points directly to the POS code. The document length is short (3235 chars), but it contains the substantive details of the transaction, not just an announcement that a report is attached, thus it is classified as the transaction report itself.
2023-10-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Transaction in Own Shares' and details the number of ordinary shares purchased by the company as part of its 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS (London Stock Exchange's news service) confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2023-10-17 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.